An Open-Label, Randomized, Multicenter Phase IIa Study Evaluating Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Pertuzumab (Primary) ; Capecitabine; Cisplatin; Trastuzumab
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Pharmacokinetics
- Acronyms JOSHUA
- Sponsors Roche
- 25 Jan 2018 This trial has been completed in Netherlands.
- 21 Nov 2017 This trial has been completed in Spain (End date: 2017-10-31), according to European Clinical Trials Database.
- 14 Nov 2017 This trial has been completed in Belgium, according to European Clinical Trials Database.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History